The United States Food and Drug Administration (FDA) has approved IPL for telangiectasias, photorejuvenation, facial wrinkles, hyperpigmentation, lentigines, ephelides, melasma, rosacea, acne vulgaris, poikiloderma of Civatte, port-wine stains, hemangiomas, leg veins, venous malformations, and removal of unwanted hair.